Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Pharma

Whoever's closest to the consumer will be the gatekeeper of the industry.

Principal, Health & Life Sciences, Organizational Effectiveness, Oliver Wyman
Principal, Oliver Wyman
Senior Consultant, Oliver Wyman

Physicians are best positioned to curtail the $265 billion wasted annually on unneeded care.

Global Head, Health Services, Oliver Wyman
Professor of Surgery and Health Policy, Johns Hopkins Medicine
Principal, Health & Life Sciences, Oliver Wyman

As merger activity heightens, some leverage retail with pharma to meet consumer demand.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

Those challengers who address critical patient needs beyond traditional treatment will become a force to be reckoned with.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Chief Strategy Officer, BCBS of Massachusetts
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

How pharmaceutical companies can better define, measure, and deliver value to patients.

Principal, Health & Life Sciences, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

The key to measurement-based digital mental healthcare intervention and assessment? A patient's smartphone.

Traditional retailers are now getting into the health business. What does it all mean, and where should corporate directors focus next?

Partner, Health & Life Sciences, Oliver Wyman

Our new advice for the Blues, who are in a formative period as market trends create both sizable risk and sizable opportunity.

Principal, Oliver Wyman Actuarial Consulting
Global Head, Health Services, Oliver Wyman
Principal, Oliver Wyman

A discussion on how mega mergers affect consumers and how consolidation is driving the new future of healthcare.

Insights in your inbox

Subscribe